Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
8.48
+0.17 (2.05%)
Dec 20, 2024, 4:00 PM EST - Market closed
Inogen Market Cap
Inogen has a market cap or net worth of $201.98 million as of December 20, 2024. Its market cap has increased by 49.17% in one year.
Market Cap
201.98M
Enterprise Value
101.46M
1-Year Change
49.17%
Ranking
Category
Stock Price
$8.48
Market Cap Chart
Since February 14, 2014, Inogen's market cap has decreased from $274.90M to $201.98M, a decrease of -26.53%. That is a compound annual growth rate of -2.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 202.00M | 57.81% |
| Dec 29, 2023 | 128.00M | -71.67% |
| Dec 30, 2022 | 451.80M | -41.52% |
| Dec 31, 2021 | 772.60M | -21.82% |
| Dec 31, 2020 | 988.20M | -34.26% |
| Dec 31, 2019 | 1.50B | -43.75% |
| Dec 31, 2018 | 2.67B | 7.54% |
| Dec 29, 2017 | 2.49B | 82.61% |
| Dec 30, 2016 | 1.36B | 72.72% |
| Dec 31, 2015 | 787.90M | 34.82% |
| Dec 31, 2014 | 584.40M | 112.59% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 200.93M |
| Lexeo Therapeutics | 199.72M |
| Atai Life Sciences | 199.68M |
| MacroGenics | 199.59M |
| Akso Health Group | 198.11M |
| Biodesix | 197.84M |
| Verastem | 197.61M |
| Inventiva | 196.18M |